Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk factors for relapse of autoimmune hepatitis in Japan: A nationwide survey.
Takahashi A, Ohira H, Abe K, Zeniya M, Abe M, Arinaga-Hino T, Nakamoto N, Takaki A, Kang JH, Joshita S, Suzuki Y, Koike K, Inui A, Tanaka A; Japan Autoimmune Hepatitis Study Group. Takahashi A, et al. Among authors: takaki a. Hepatol Res. 2022 Jul;52(7):597-602. doi: 10.1111/hepr.13766. Epub 2022 Apr 13. Hepatol Res. 2022. PMID: 35355374
Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis.
Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Okamoto R, Takaguchi K, Ikeda H, Makino Y, Ando M, Sakaguchi K, Yamamoto K. Miyake Y, et al. Among authors: takaki a. Hepatol Res. 2009 Mar;39(3):241-6. doi: 10.1111/j.1872-034X.2008.00454.x. Epub 2008 Nov 26. Hepatol Res. 2009. PMID: 19054143
Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood.
Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Okamoto R, Takaguchi K, Ikeda H, Makino Y, Sakaguchi K, Ando M, Yamamoto K. Miyake Y, et al. Among authors: takaki a. Hepatol Res. 2009 Aug;39(8):766-71. doi: 10.1111/j.1872-034X.2009.00510.x. Epub 2009 Apr 3. Hepatol Res. 2009. PMID: 19473431
Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine.
Kobashi H, Miyake Y, Ikeda F, Yasunaka T, Nishino K, Moriya A, Kubota J, Nakamura S, Takaki A, Nouso K, Yamada G, Yamamoto K. Kobashi H, et al. Among authors: takaki a. Hepatol Res. 2011 May;41(5):405-16. doi: 10.1111/j.1872-034X.2011.00785.x. Epub 2011 Mar 21. Hepatol Res. 2011. PMID: 21435126
Fulminant hepatitis: Who survives without liver transplantation?
Miyake Y, Yasunaka T, Ikeda F, Takaki A, Nouso K, Yamamoto K. Miyake Y, et al. Among authors: takaki a. Hepatol Res. 2012 Jan;42(1):60-7. doi: 10.1111/j.1872-034X.2011.00894.x. Epub 2011 Oct 11. Hepatol Res. 2012. PMID: 21988414
382 results